HIV vaccine might offer survival advantage

Jun 12, 2006

U.S. researchers say even if an HIV vaccine doesn't offer perfect protection against the virus, it might provide a survival advantage after infection.

Such a survival advantage was observed in two monkey studies sponsored by the National Institute of Allergy and Infectious Diseases.

One team of researchers was led by Dr. Norman Letvin of Beth Israel Deaconess Medical Center, Harvard Medical School and the NIAID Vaccine Research Center, while the other team was led by Mario Roederer of the VRC.

Both teams found monkeys vaccinated against simian immunodeficiency virus -- a close relative of HIV that causes an AIDS-like disease in monkeys -- and then exposed to the virus survived significantly longer than unvaccinated animals exposed to SIV.

The studies also identified a measurable marker of SIV vaccine effectiveness in monkeys -- something known as an immune correlate of vaccine efficacy. But the researchers say further study is needed to determine if the immune correlate could predict the effectiveness of a vaccine against HIV in humans.

The research appears in this week's issue of Science and this month's issue of the Journal of Experimental Medicine.

Copyright 2006 by United Press International

Explore further: UN: Goals helped lift one billion people from extreme poverty

Related Stories

Some monkeys born with gene that protects against AIDS

May 04, 2011

A certain gene in some monkeys can help boost vaccine protection against simian immunodeficiency virus (SIV), a trait that could help researchers develop better AIDS vaccines for humans, suggested a study ...

HIV vaccine strategy expands immune responses

Mar 03, 2010

Two teams of researchers -- including Los Alamos National Laboratory theoretical biologists Bette Korber, Will Fischer, Sydeaka Watson, and James Szinger -- have announced an HIV vaccination strategy that has been shown to ...

Novel vaccine approach offers hope in fight against HIV

May 17, 2009

A research team may have broken the stubborn impasse that has frustrated the invention of an effective HIV vaccine, by using an approach that bypasses the usual path followed by vaccine developers. By using ...

Vaccines from a reactor

Mar 02, 2015

In the event of an impending global flu pandemic, vaccine production could quickly reach its limits, as flu vaccines are still largely produced in embryonated chicken eggs. Udo Reichl, Director at the Max ...

New Research Investigates How Diseases Spread in Primates

Aug 27, 2012

A new international study has investigated how diseases are shared among species of primates with a view to predicting what diseases may emerge in humans in the future. The findings aim to help in the fight against these ...

Recommended for you

UN: Goals helped lift one billion people from extreme poverty

44 minutes ago

A 15-year effort to implement eight goals adopted by world leaders at the start of the new millennium has helped lift more than one billion people out of extreme poverty, enabled more girls to go to school than ever before, ...

New Brazil rules seek to cut Cesarean craze

1 hour ago

New regulations aimed at rolling back Brazil's obsession with Cesarean sections took effect Monday, with the government hoping it can steer the country from its status as a world leader in C-section births.

Teva to lift bid for Mylan: report

1 hour ago

Israeli pharmaceutical giant Teva plans to increase its bid for rival Mylan and could announce the move as soon as this week, according to a US media report Monday.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.